List of life saving transplantations

FamiCord Group is the most experienced bank in Europe in preparing and releasing stem cells for transplantations. We are advancing potential stem cell uses by partnering with leading medical institutions.

Filter by:

No. Cell source Indication Area of medicine Year Type of therapy Country Age
1 cord blood CD40 ligand deficiency hematology 2017 standard therapy Turkey 9,6
2 cord blood talassemia major hematology 2017 standard therapy Turkey 4,0
3 cord blood talassemia major hematology 2017 standard therapy Turkey 4,1
4 cord blood cerebral palsy neurology 2017 experimental therapy Poland 2,2
5 cord blood cerebral palsy neurology 2017 experimental therapy Poland 5,4
6 cord blood cerebral palsy neurology 2017 experimental therapy Poland 10,3
7 cord blood autism neurology 2017 experimental therapy Poland 4,11
8 cord blood acute myeloid leukemia hematology 2016 standard therapy Jordan 6
9 cord blood autism neurology 2016 experimental therapy Poland 6
10 cord blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 7
11 cord blood acute lymphoblastic leukemia hematology 2015 standard therapy Poland 4
12 cord blood acute lymphoblastic leukemia hematology 2014 standard therapy Turkey 7
13 cord blood aplastic anaemia hematology 2013 standard therapy Poland 3
14 cord blood acute myeloid leukemia hematology 2013 standard therapy Poland 3
15 cord blood beta-talassemia; agranulocytosis hematology 2013 standard therapy Turkey 8
16 cord blood X - linked lymphoproliferative syndrome hematology 2013 standard therapy Poland 10/12
17 cord blood severe aplastic anaemia hematology 2012 standard therapy Hungary 3
18 cord blood anaemia, talassemia major hematology 2012 standard therapy Turkey 6
19 cord blood talassemia major, acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 3,5
20 cord blood T-acute lymphoblastic leukemia hematology 2012 standard therapy Turkey 5
21 cord blood Fanconi anemia hematology 2011 standard therapy Poland 12
22 cord blood acute myeloid leukemia hematology 2011 standard therapy Hungary 2
23 cord blood acute lymphoblastic leukemia hematology 2011 standard therapy Poland 5
24 cord blood histiocytosis hematology 2011 standard therapy Poland 2,5
25 cord blood chronic granulomatous disease hematology 2011 standard therapy Poland 7,5
26 cord blood pre -B acute lymphoblastic leukemia hematology 2010 standard therapy Hungary 1,5
27 cord blood myelodysplastic syndrome hematology 2009 standard therapy Poland 5
28 cord blood acute lymphoblastic leukemia hematology 2008 standard therapy Poland 5
29 cord blood cerebral ischemia neurology 2008 experimental therapy Poland 1,5
30 cord blood neuroblastoma hematology 2007 standard therapy Poland 8
31 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 2,10
32 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 67,11
33 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 37,9
34 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 71,7
35 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland no data
36 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7,11
37 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 47,6
38 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 44,1
39 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 34,11
40 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 58,10
41 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 49,0
42 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 37,4
43 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 37,7
44 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 26,11
45 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56,7
46 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 48,11
47 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46,3
48 cord tissue (Wharton's jelly) cartilage damage orthopedics 2017 experimental therapy Poland 61,5
49 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 34,1
50 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 52,9
51 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2017 experimental therapy Poland 23,9
52 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 31,6
53 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2017 experimental therapy Poland 33,4
54 cord tissue (Wharton's jelly) tetraparesis spastica neurology 2017 experimental therapy Poland 29,4
55 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 24,9
56 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 10,6
57 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 30,0
58 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 56,8
59 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 65,2
60 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 45,9
61 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 28,6
62 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 44,2
63 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 41,4
64 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 25,8
65 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 75,9
66 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 23,7
67 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 43,4
68 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 39,0
69 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,3
70 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 39,0
71 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 42,11
72 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 30,9
73 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 12,11
74 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 8,5
75 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2017 experimental therapy Poland 58,9
76 cord tissue (Wharton's jelly) cri du chat syndrome neurology 2017 experimental therapy Poland 8,6
77 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 18,7
78 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 59,8
79 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 22,1
80 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2017 experimental therapy Poland 28,11
81 cord tissue (Wharton's jelly) epilepsia neurology 2017 experimental therapy Poland 3,1
82 cord tissue (Wharton's jelly) cranium bifidum neurology 2017 experimental therapy Poland 5,2
83 cord tissue (Wharton's jelly) transverse myelitis neurology 2017 experimental therapy Poland 8,3
84 cord tissue (Wharton's jelly) syringomielia neurology 2017 experimental therapy Poland 42,6
85 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 64,9
86 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 47,2
87 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 38,5
88 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 56,7
89 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 13,4
90 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 21,10
91 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 5,0
92 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 41,0
93 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 52,1
94 cord tissue (Wharton's jelly) cerebral palsy; neonatal cerebral leukomalacia neurology 2017 experimental therapy Poland 1,9
95 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 11,11
96 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2017 experimental therapy Poland 26,10
97 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 9,1
98 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 11,5
99 cord tissue (Wharton's jelly) congenital fiber-type disproportion myopathy neurology 2017 experimental therapy Poland 1,10
100 cord tissue (Wharton's jelly) chronic myeloid leukemia hematology 2017 experimental therapy Poland 5,11
101 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 61,5
102 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 40,11
103 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 48,1
104 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 1,11
105 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 37,11
106 cord tissue (Wharton's jelly) arthrogryposis multiplex congenita neurology 2017 experimental therapy Poland 1,7
107 cord tissue (Wharton's jelly) encephalopathy; cerebral palsy neurology 2017 experimental therapy Poland 4,4
108 cord tissue (Wharton's jelly) cerebral palsy; epilepsy neurology 2017 experimental therapy Poland 5,8
109 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2017 experimental therapy Poland 6,4
110 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 15,4
111 cord tissue (Wharton's jelly) traumatic brain injury neurology 2017 experimental therapy Poland 9,4
112 cord tissue (Wharton's jelly) no bone adhesion orthopedics 2017 experimental therapy Poland 14,1
113 cord tissue (Wharton's jelly) no bone adhesion orthopedics 2017 experimental therapy Poland 17,11
114 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 69,10
115 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2017 experimental therapy Poland 24,9
116 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 37,7
117 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 31,1
118 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 52,11
119 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 27,11
120 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 45,4
121 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 34,10
122 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 31,6
123 cord tissue (Wharton's jelly) hydrocephalus; neonatal cerebral leukomalacia neurology 2017 experimental therapy Poland 2,3
124 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 6,3
125 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7,11
126 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 3,5
127 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 6,3
128 cord tissue (Wharton's jelly) syndrom IFAP hematology 2017 experimental therapy Poland 3,5
129 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 52,0
130 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 13,0
131 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 11,10
132 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 66,11
133 cord tissue (Wharton's jelly) ischemia within the optic nerve ophthalmology 2017 experimental therapy Poland 37,11
134 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 35,1
135 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 4,11
136 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 77,2
137 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 36,11
138 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 63,11
139 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 35,6
140 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 31,9
141 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 31,9
142 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 10,2
143 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 33,5
144 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,7
145 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 12,5
146 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,9
147 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,3
148 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 5,0
149 cord tissue (Wharton's jelly) hypoxia-ischemic encephalopathy neurology 2017 experimental therapy Poland 1,9
150 cord tissue (Wharton's jelly) Krabbe disease neurology 2017 experimental therapy Poland 6,3
151 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2017 experimental therapy Poland 24,6
152 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,6
153 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 45,5
154 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 31,5
155 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2017 experimental therapy Poland 48,10
156 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 62,5
157 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2017 experimental therapy Poland 60,5
158 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 6,1
159 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4,8
160 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 6,4
161 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 6,3
162 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 46,0
163 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 49,1
164 cord tissue (Wharton's jelly) condition after encephalitis neurology 2017 experimental therapy Poland 19,7
165 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 35,4
166 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 1,10
167 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 6,8
168 cord tissue (Wharton's jelly) encephalopathy; cerebral palsy neurology 2017 experimental therapy Poland 1,5
169 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 7,0
170 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 13,6
171 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 6,7
172 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 32,3
173 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2017 experimental therapy Poland 46,9
174 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 54,10
175 cord tissue (Wharton's jelly) dystrophia myotonica neurology 2017 experimental therapy Poland 41,11
176 cord tissue (Wharton's jelly) global developmental delay neurology 2017 experimental therapy Poland 4,7
177 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 56,4
178 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 4,1
179 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 3,6
180 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2017 experimental therapy Poland 33,4
181 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 42,1
182 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2017 experimental therapy Poland 2,4
183 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 30,11
184 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 39,7
185 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 4,8
186 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 8,2
187 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 3,4
188 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 2,11
189 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2017 experimental therapy Poland 7,9
190 cord tissue (Wharton's jelly) arthrogryposis multiplex congenita neurology 2017 experimental therapy Poland 3,5
191 cord tissue (Wharton's jelly) dystrophia myotonica neurology 2017 experimental therapy Poland 3,2
192 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 63,2
193 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2017 experimental therapy Poland 76,10
194 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /BMD neurology 2017 experimental therapy Poland 23,9
195 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,7
196 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 43,8
197 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2017 experimental therapy Poland 74,5
198 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 64,7
199 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,6
200 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 70,11
201 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 65,1
202 cord tissue (Wharton's jelly) encephalopathy neurology 2017 experimental therapy Poland 5,5
203 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 8,4
204 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 15,1
205 cord tissue (Wharton's jelly) spina bifida neurology 2017 experimental therapy Poland 5,8
206 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2017 experimental therapy Poland 51,3
207 cord tissue (Wharton's jelly) muscular dystrophy neurology 2017 experimental therapy Poland 12,10
208 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2017 experimental therapy Poland 26,9
209 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 18,4
210 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 10,8
211 cord tissue (Wharton's jelly) autism neurology 2017 experimental therapy Poland 13,1
212 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 7,9
213 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,5
214 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,7
215 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,5
216 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 5,1
217 cord tissue (Wharton's jelly) cerebral palsy neurology 2017 experimental therapy Poland 3,4
218 cord tissue (Wharton's jelly) Devic’s disease neurology 2017 experimental therapy Poland 45,2
219 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Poland 6
220 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Germany 76
221 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Turkey 22
222 bone marrow chronic granulomatous disease hematology 2017 standard therapy Poland 2
223 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Germany 65
224 bone marrow myelodysplastic syndrome hematology 2017 standard therapy Italy 60
225 bone marrow myelodysplastic syndrome hematology 2017 standard therapy USA 61
226 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Russia 30
227 bone marrow chronic granulomatous disease hematology 2017 standard therapy Poland 4
228 bone marrow leukemia hematology 2017 standard therapy USA 40
229 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 10
230 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Hungary 14
231 bone marrow severe combined immunodeficiency hematology 2017 standard therapy Turkey 6
232 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 55
233 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 67
234 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Poland 16
235 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Lithuania 1
236 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 13
237 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Italy 38
238 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 9
239 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Canada 1
240 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 59
241 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy USA 21
242 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Turkey 2
243 bone marrow hyper IgM syndrome hematology 2017 standard therapy Finland 2
244 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy Austria 3
245 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 1
246 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 59
247 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 57
248 bone marrow pure red cell aplasia hematology 2017 standard therapy USA 5
249 bone marrow thalassemia major hematology 2017 standard therapy Turkey 11
250 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 10
251 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 68
252 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 60
253 bone marrow Fanconi anaemia hematology 2017 standard therapy Russia 10
254 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 10
255 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 17
256 bone marrow acute myelogenous leukemia hematology 2017 standard therapy USA 51
257 bone marrow juvenile myelomonocytic leukemia hematology 2017 standard therapy Finland 1
258 bone marrow acute megakaryocytic leukemia hematology 2017 standard therapy Spain 2
259 bone marrow chronic myeloid leukemia hematology 2017 standard therapy USA 51
260 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Italy 56
261 bone marrow acute myelogenous leukemia hematology 2017 standard therapy Russia 54
262 bone marrow acute myelogenous leukemia hematology 2017 standard therapy France 24
263 bone marrow  severe combined immunodeficiency hematology 2017 standard therapy Poland 1
264 bone marrow acute lymphoblastic leukemia hematology 2017 standard therapy United Kingdom 8
265 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,11
266 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44,5
267 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,8
268 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 32,2
269 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 64
270 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 62,5
271 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 18,4
272 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 48,8
273 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,3
274 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 35,3
275 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,7
276 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,2
277 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2016 experimental therapy Poland 3,10
278 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 14
279 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 6
280 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 65,8
281 cord tissue (Wharton's jelly) leukodystrophy neurology 2016 experimental therapy Poland 2,9
282 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59,4
283 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6
284 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,11
285 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 12,11
286 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,7
287 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20,3
288 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 53
289 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 33,5
290 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 22,2
291 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,3
292 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,5
293 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 29,11
294 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33,4
295 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 37,4
296 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 39,3
297 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 7,11
298 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 28
299 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 69,6
300 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 33,11
301 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 20,7
302 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 24,5
303 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 25,6
304 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,5
305 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 39,10
306 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 60,10
307 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,9
308 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 44,8
309 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 25,4
310 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 10,10
311 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 63,2
312 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,11
313 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,9
314 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 46,9
315 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58
316 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2016 experimental therapy Poland 19,2
317 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55
318 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58,1
319 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,7
320 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 52,6
321 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59,11
322 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 28,8
323 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,9
324 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 34,9
325 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 69,3
326 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 47,9
327 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 18,8
328 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,9
329 cord tissue (Wharton's jelly) traumatic brain injury neurology 2016 experimental therapy Poland 54,9
330 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 19,5
331 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59
332 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,9
333 cord tissue (Wharton's jelly) tetraparesis orthopedics 2016 experimental therapy Poland 27,9
334 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14,9
335 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 42,7
336 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 60,5
337 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,2
338 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 11,3
339 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,11
340 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2016 experimental therapy Poland 49,8
341 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2016 experimental therapy Poland 69,9
342 cord tissue (Wharton's jelly) optic atrophy ophthalmology 2016 experimental therapy Poland 69,1
343 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 13,11
344 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 45,1
345 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,4
346 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 36,1
347 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 59, 1
348 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,2
349 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,7
350 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,1
351 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 46,1
352 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72,4
353 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,3
354 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,1
355 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,8
356 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 64,7
357 cord tissue (Wharton's jelly) malformation syndrome neurology 2016 experimental therapy Poland 3,5
358 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 64,2
359 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 38
360 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6,10
361 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 2,11
362 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62,8
363 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,5
364 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 51,3
365 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,2
366 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 55,4
367 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 54,8
368 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 33,10
369 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 41,4
370 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 49,3
371 cord tissue (Wharton's jelly) choroideremia ophthalmology 2016 experimental therapy Poland 50,8
372 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 63,1
373 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 7,4
374 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,4
375 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 73,7
376 cord tissue (Wharton's jelly) leukodystrophy neurology 2016 experimental therapy Poland 2,11
377 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,6
378 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 48,3
379 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 32,7
380 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2016 experimental therapy Poland 3,11
381 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 61,11
382 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 45,8
383 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,4
384 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 79,2
385 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72,6
386 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 48,4
387 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2016 experimental therapy Poland 6,11
388 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2016 experimental therapy Poland 9,7
389 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 54,2
390 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 50,9
391 cord tissue (Wharton's jelly) limb-girdle muscular dystrophy neurology 2016 experimental therapy Poland 22
392 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14,7
393 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,9
394 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 62,6
395 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 58,10
396 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,6
397 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,2
398 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,9
399 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,4
400 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,7
401 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 58,1
402 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 4,8
403 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 1,5
404 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3
405 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 9,9
406 cord tissue (Wharton's jelly) global developmental delay neurology 2016 experimental therapy Poland 6,9
407 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,8
408 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 39,6
409 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 13,2
410 cord tissue (Wharton's jelly) developmental delay neurology 2016 experimental therapy Poland 7,4
411 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 7,4
412 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 66
413 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 38,1
414 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 8,4
415 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3
416 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 79,8
417 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 54,3
418 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 14,4
419 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 47,11
420 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,3
421 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,2
422 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 23,6
423 cord tissue (Wharton's jelly) age-related macular degeneration ophthalmology 2016 experimental therapy Poland 86,5
424 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 54,6
425 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 68,5
426 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 13,7
427 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 2,2
428 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 5,0
429 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 12,11
430 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 12,3
431 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 1,3
432 cord tissue (Wharton's jelly) developmental delay neurology 2016 experimental therapy Poland 2,7
433 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 3,3
434 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 59,6
435 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 34,2
436 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 30,3
437 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 17,10
438 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 37,11
439 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 31,9
440 cord tissue (Wharton's jelly) ataxia hereditaria neurology 2016 experimental therapy Poland 69
441 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 31,9
442 cord tissue (Wharton's jelly) no data ophthalmology 2016 experimental therapy Poland 66,1
443 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 53,4
444 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 60,8
445 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 10,8
446 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 3
447 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2,11
448 cord tissue (Wharton's jelly) encephalopathy neurology 2016 experimental therapy Poland 4,3
449 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland no data
450 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 59,4
451 cord tissue (Wharton's jelly) atrophy of the optic nerves ophthalmology 2016 experimental therapy Poland 20,11
452 cord tissue (Wharton's jelly) patella cartilage damage orthopedics 2016 experimental therapy Poland 53
453 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 24,5
454 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 34, 7
455 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 32,3
456 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 65,9
457 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 52,7
458 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 71,5
459 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 60,7
460 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 1,10
461 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 7,6
462 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2016 experimental therapy Poland 1,10
463 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 29,7
464 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68,5
465 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2016 experimental therapy Poland 8/12
466 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 44,5
467 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 9,2
468 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 24,5
469 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,7
470 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 15,9
471 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 6,8
472 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 10,3
473 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 16,4
474 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 6
475 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2016 experimental therapy Poland 41,8
476 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 51,9
477 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 49,3
478 cord tissue (Wharton's jelly) autism neurology 2016 experimental therapy Poland 20,9
479 cord tissue (Wharton's jelly) fetal alcohol spectrum disorders neurology 2016 experimental therapy Poland 5,2
480 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 13,10
481 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 58,4
482 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 68,2
483 cord tissue (Wharton's jelly) chondronecrosis femoral condyle orthopedics 2016 experimental therapy Poland 54,11
484 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,4
485 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 41,2
486 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 72,1
487 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,8
488 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 2,11
489 cord tissue (Wharton's jelly) tetraparesis spastica orthopedics 2016 experimental therapy Poland 18
490 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,1
491 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 48,1
492 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 56,3
493 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 66,10
494 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland no data
495 cord tissue (Wharton's jelly) gangliosidosis t. 1 neurology 2016 experimental therapy Poland 1,4
496 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 14,9
497 cord tissue (Wharton's jelly) epileptic encephalopathy neurology 2016 experimental therapy Poland 3,6
498 cord tissue (Wharton's jelly) polineuropathy neurology 2016 experimental therapy Poland 70,8
499 cord tissue (Wharton's jelly) diffuse cartilage damage left medial compartment of the knee orthopedics 2016 experimental therapy Poland 50,5
500 cord tissue (Wharton's jelly) Stargardt's disease ophthalmology 2016 experimental therapy Poland 37,7
501 cord tissue (Wharton's jelly) myopia, hyperopia, astigmatism, abnormal refraction and accommodation, optic atrophy ophthalmology 2016 experimental therapy Poland 37,1
502 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2016 experimental therapy Poland 33,5
503 cord tissue (Wharton's jelly) epilepsia neurology 2016 experimental therapy Poland 16,2
504 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 3,7
505 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 17,9
506 cord tissue (Wharton's jelly) injuries to the spinal nerves neurology 2016 experimental therapy Poland 5/12
507 cord tissue (Wharton's jelly) cartilage damage orthopedics 2016 experimental therapy Poland 57,6
508 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 4,8
509 cord tissue (Wharton's jelly) muscular dystrophy neurology 2016 experimental therapy Poland 44,7
510 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /DMD neurology 2016 experimental therapy Poland 10
511 cord tissue (Wharton's jelly) cerebral palsy neurology 2016 experimental therapy Poland 4,4
512 cord tissue (Wharton's jelly) spina bifida neurology 2016 experimental therapy Poland 4,9
513 cord tissue (Wharton's jelly) cerebellar syndrome neurology 2016 experimental therapy Poland 28,6
514 cord tissue (Wharton's jelly) neurodevelopmental disorders neurology 2016 experimental therapy Poland 4,5
515 cord tissue (Wharton's jelly) tetraparesis orthopedics 2016 experimental therapy Poland 27,2
516 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 61,2
517 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2016 experimental therapy Poland 44,8
518 cord tissue (Wharton's jelly) degeneration of the cartilage of the knee joint orthopedics 2016 experimental therapy Poland 54,3
519 cord tissue (Wharton's jelly) dystrophia progressiva pseudohypertrophica /BMD neurology 2016 experimental therapy Poland 19,2
520 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 15,0
521 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 31,11
522 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2016 experimental therapy Poland 33,4
523 cord tissue (Wharton's jelly) endometrial atrophy ginecology 2016 experimental therapy Poland 37,3
524 cord tissue (Wharton's jelly) endometrial atrophy ginecology 2016 experimental therapy Poland 39,1
525 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2016 experimental therapy Poland 38,4
526 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2016 experimental therapy Poland 44,5
527 cord tissue (Wharton's jelly) meniscus damage orthopedics 2016 experimental therapy Poland 35,5
528 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 60,8
529 cord tissue (Wharton's jelly) premature ovarian failure ginecology 2016 experimental therapy Poland 23,4
530 cord tissue (Wharton's jelly) premature ovarian failure ginecology 2016 experimental therapy Poland 34,9
531 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2016 experimental therapy Poland 55,5
532 bone marrow osteopetrosis metabolic 2016 standard therapy Russia 6
533 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Romania 2
534 bone marrow T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Italy 4
535 bone marrow no data n/a 2016 standard therapy Italy 3
536 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 64
537 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 9
538 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Spain 55
539 bone marrow Fanconi anaemia hematology 2016 standard therapy Estonia 7
540 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 6
541 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 64
542 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Italy 14
543 bone marrow biphenotypic leukemia hematology 2016 standard therapy Brazil 27
544 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Germany 7
545 bone marrow osteopetrosis metabolic 2016 standard therapy Germany 1
546 bone marrow severe aplastic anaemia hematology 2016 standard therapy France 9
547 bone marrow no data n/a 2016 standard therapy Poland 7
548 bone marrow Hurler syndrome metabolic 2016 standard therapy United Kingdom 2
549 bone marrow  severe combined immunodeficiency hematology 2016 standard therapy Turkey 4
550 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Canada 11
551 bone marrow myelofibrosis hematology 2016 standard therapy Germany 31
552 bone marrow DiGeorge syndrome hematology 2016 standard therapy Netherlands 24
553 bone marrow Hodgkin’s lymphoma hematology 2016 standard therapy Italy 17
554 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Belarus 12
555 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 18
556 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Poland 7/12
557 bone marrow severe aplastic anaemia hematology 2016 standard therapy France 9
558 bone marrow severe aplastic anaemia / paroxymal nocturnal haemoglobinuria hematology 2016 standard therapy Poland 17
559 bone marrow myelodysplastic syndrome hematology 2016 standard therapy Hungary 1
560 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Italy 67
561 bone marrow myelodysplastic syndrome hematology 2016 standard therapy Spain 56
562 bone marrow Fanconi anaemia hematology 2016 standard therapy Netherlands 41
563 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy France 5
564 bone marrow acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 29
565 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 25
566 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy New Zealand 1
567 bone marrow severe combined immunodeficiency hematology 2016 standard therapy Germany 12
568 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Poland 5
569 bone marrow no data n/a 2016 standard therapy Poland 33
570 bone marrow non-Hodgkin lymphoma hematology 2016 standard therapy Italy 46
571 bone marrow aplastic anaemia hematology 2016 standard therapy Austria 20
572 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Croatia 33
573 bone marrow myeloproliferative syndrome hematology 2016 standard therapy Poland 22
574 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Ireland 39
575 bone marrow Diamond-Balckfan anaemia hematology 2016 standard therapy Germany 2
576 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 9
577 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Belarus 15
578 bone marrow juvenile myelomonocytic leukemia hematology 2016 standard therapy Germany 3
579 bone marrow acute myelogenous leukemia hematology 2016 standard therapy Finland 45
580 bone marrow anaemia hematology 2016 standard therapy Germany 16
581 bone marrow acute lymphoblastic leukemia hematology 2016 standard therapy Germany 6
582 bone marrow anaemia hematology 2016 standard therapy Italy 5
583 bone marrow high-risk acute lymphoblastic leukemia hematology 2016 standard therapy Poland 18
584 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 1,4
585 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 5,4
586 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2015 experimental therapy Poland 23,2
587 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,6
588 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61
589 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 56
590 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 51
591 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 65
592 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 60
593 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 52
594 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 3,8
595 cord tissue (Wharton's jelly) decerebration rigidity neurology 2015 experimental therapy Poland 9,6
596 cord tissue (Wharton's jelly) bilateral blindness ophthalmology 2015 experimental therapy Poland 36,10
597 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 11/12
598 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 7,1
599 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 15,8
600 cord tissue (Wharton's jelly) ceroid lipofuscinosis neurology 2015 experimental therapy Poland 5,1
601 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 14,5
602 cord tissue (Wharton's jelly) ceroid lipofuscinosis neurology 2015 experimental therapy Poland 7,10
603 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 3
604 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 7,1
605 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 13,1
606 cord tissue (Wharton's jelly) spina bifida neurology 2015 experimental therapy Poland 2,4
607 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 59,4
608 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 31,2
609 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 5,1
610 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 12,5
611 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 8,11
612 cord tissue (Wharton's jelly) delayed psychomotor development, deafness neurology 2015 experimental therapy Poland 3,3
613 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,5
614 cord tissue (Wharton's jelly) traumatic encephalopathy neurology 2015 experimental therapy Poland 20,11
615 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 18,8
616 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 2,7
617 cord tissue (Wharton's jelly) adrenoleukodystrophy; encephalopathy neurology 2015 experimental therapy Poland 23
618 cord tissue (Wharton's jelly) adrenoleukodystrophy neurology 2015 experimental therapy Poland 11,11
619 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 40
620 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 26,1
621 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 37,1
622 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58
623 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 35,6
624 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2015 experimental therapy Poland 11/12
625 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 44,6
626 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2015 experimental therapy Poland 15,8
627 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,6
628 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2015 experimental therapy Poland 66,2
629 cord tissue (Wharton's jelly) iatrogenic spinal cord injury neurology 2015 experimental therapy Poland 17,2
630 cord tissue (Wharton's jelly) optic neuropathy ophthalmology 2015 experimental therapy Poland 45,10
631 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 62
632 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 51,5
633 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 12,10
634 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 26,5
635 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 27
636 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 4,10
637 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 6,1
638 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 4,6
639 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 63,11
640 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 32,10
641 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 22
642 cord tissue (Wharton's jelly) sclerosis multiplex neurology 2015 experimental therapy Poland 33,3
643 cord tissue (Wharton's jelly) delayed psychomotor development neurology 2015 experimental therapy Poland 3,6
644 cord tissue (Wharton's jelly) spina bifida neurology 2015 experimental therapy Poland 2
645 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2015 experimental therapy Poland 18,7
646 cord tissue (Wharton's jelly) spinocerebellar ataxia neurology 2015 experimental therapy Poland 24,3
647 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 67,6
648 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 5,6
649 cord tissue (Wharton's jelly) polineuropathy neurology 2015 experimental therapy Poland 74,2
650 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 37,6
651 cord tissue (Wharton's jelly) stroke neurology 2015 experimental therapy Poland 62,8
652 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 58,10
653 cord tissue (Wharton's jelly) facio-scapulo-humeral muscular dystrophy neurology 2015 experimental therapy Poland 30,1
654 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2015 experimental therapy Poland 10
655 cord tissue (Wharton's jelly) severe developmental delay neurology 2015 experimental therapy Poland 1,1
656 cord tissue (Wharton's jelly) spinal muscular atrophy neurology 2015 experimental therapy Poland 26,2
657 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 46,2
658 cord tissue (Wharton's jelly) autism neurology 2015 experimental therapy Poland 8,7
659 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 8/12
660 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 6,6
661 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 48,7
662 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 21,4
663 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 9,9
664 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2015 experimental therapy Poland 13,4
665 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 61,3
666 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2015 experimental therapy Poland 54
667 cord tissue (Wharton's jelly) intracranial injury neurology 2015 experimental therapy Poland 24,3
668 cord tissue (Wharton's jelly) stroke neurology 2015 experimental therapy Poland 54,9
669 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 24,7
670 cord tissue (Wharton's jelly) gonarthrosis orthopedics 2015 experimental therapy Poland 65,9
671 cord tissue (Wharton's jelly) leukodystrophy neurology 2015 experimental therapy Poland 18,8
672 cord tissue (Wharton's jelly) spinal cord injury orthopedics 2015 experimental therapy Poland 34,4
673 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 1,6
674 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 14,10
675 cord tissue (Wharton's jelly) anterior ischemic optic neuropathy ophthalmology 2015 experimental therapy Poland 54,10
676 cord tissue (Wharton's jelly) cerebral palsy neurology 2015 experimental therapy Poland 16,9
677 cord tissue (Wharton's jelly) retinitis pigmentosa ophthalmology 2015 experimental therapy Poland 34,5
678 cord tissue (Wharton's jelly) cerebellar ataxia neurology 2015 experimental therapy Poland 26,1
679 cord tissue (Wharton's jelly) encephalopathy neurology 2015 experimental therapy Poland 11,2
680 cord tissue (Wharton's jelly) adrenoleukodystrophy; encephalopathy neurology 2015 experimental therapy Poland 8,4
681 cord tissue (Wharton's jelly) neuropathy neurology 2014 experimental therapy Poland 23,6
682 cord tissue (Wharton's jelly) autism neurology 2014 experimental therapy Poland 12,6
683 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2014 experimental therapy Poland 6
684 cord tissue (Wharton's jelly) central motor coordination impairment after hypoxic ischaemia lesion at birth neurology 2014 experimental therapy Poland 2,1
685 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 60,10
686 cord tissue (Wharton's jelly) amyotrophic lateral sclerosis neurology 2014 experimental therapy Poland 24,1
687 cord tissue (Wharton's jelly) autism neurology 2014 experimental therapy Poland 8,3
688 cord tissue (Wharton's jelly) muscular dystrophy neurology 2014 experimental therapy Poland 6
689 cord tissue (Wharton's jelly) birth asphyxia; retinopathy neurology 2014 experimental therapy Poland 11/12
690 cord tissue (Wharton's jelly) cerebral palsy neurology 2014 experimental therapy Poland 4,10
691 cord tissue (Wharton's jelly) cerebral palsy neurology 2014 experimental therapy Poland 15,10
692 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 18,9
693 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 2,11
694 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2013 experimental therapy Poland 3,5
695 cord tissue (Wharton's jelly) acute myeloid leukemia hematology 2013 experimental therapy Poland 3,5
696 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2013 experimental therapy Poland 18,8
697 cord tissue (Wharton's jelly) chronic graft versus host disease hematology 2013 experimental therapy Poland 17,5
698 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 19,7
699 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 7,1
700 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2012 experimental therapy Poland 4,3
701 cord tissue (Wharton's jelly) acute graft versus host disease hematology 2011 experimental therapy Poland 17,2
702 peripheral blood Hurler syndrome hematology 2017 standard therapy United Kingdom 2
703 peripheral blood myeloma multiplex hematology 2017 standard therapy Germany 44
704 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 60
705 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 24
706 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy United Kingdom 51
707 peripheral blood chronic myeloproliferative neoplasm blast crisis hematology 2017 standard therapy Germany 29
708 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 43
709 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 68
710 peripheral blood chronic myeloid leukemia hematology 2017 standard therapy Turkey 29
711 peripheral blood severe aplastic anaemia hematology 2017 standard therapy Poland 14
712 peripheral blood Niemann–Pick disease hematology 2017 standard therapy Poland 2
713 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Iran 17
714 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 3
715 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 63
716 peripheral blood Common variable immunodeficiency, relapsed hemophagocytic syndrome hematology 2017 standard therapy Germany 44
717 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 65
718 peripheral blood myelofibrosis hematology 2017 standard therapy Spain 63
719 peripheral blood diffuse large B-cell lymphoma hematology 2017 standard therapy Germany 61
720 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 56
721 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 48
722 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Austria 54
723 peripheral blood myelofibrosis hematology 2017 standard therapy Denmark 63
724 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Hungary 47
725 peripheral blood no data n/a 2017 standard therapy France 39
726 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 54
727 peripheral blood Langerhans Lymphohistiocytosis hematology 2017 standard therapy Czech Republic 2
728 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 75
729 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Slovakia 64
730 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Belgium 57
731 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Russia 32
732 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 53
733 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 47
734 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy France 43
735 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 48
736 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy France 56
737 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Italy 47
738 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 3
739 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Spain 20
740 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Croatia 64
741 peripheral blood myelofibrosis hematology 2017 standard therapy Germany 66
742 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 44
743 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 46
744 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 53
745 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Netherlands 66
746 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Netherlands 75
747 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 61
748 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Sweden 63
749 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 60
750 peripheral blood myeloma multiplex hematology 2017 standard therapy Germany 56
751 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Lithuania 59
752 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 45
753 peripheral blood hemophagocytosis hematology 2017 standard therapy USA 52
754 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Brazil 12
755 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Norway 57
756 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Belgium 19
757 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy USA 45
758 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 65
759 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 64
760 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Belgium 71
761 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Turkey 46
762 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Belgium 55
763 peripheral blood no data hematology 2017 standard therapy Poland 39
764 peripheral blood aplastic anaemia hematology 2017 standard therapy United Kingdom 23
765 peripheral blood myelofibrosis hematology 2017 standard therapy USA 62
766 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 50
767 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 57
768 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Italy 58
769 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy Germany 54
770 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 32
771 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 75
772 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 42
773 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 63
774 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Australia 60
775 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 53
776 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 67
777 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 33
778 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 64
779 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Germany 56
780 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 65
781 peripheral blood B-cell Chronic lymphoblastic leukemia hematology 2017 standard therapy Germany 48
782 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Poland 47
783 peripheral blood osteopetrosis hematology 2017 standard therapy Israel 3
784 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 56
785 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 55
786 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Canada 56
787 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Lithuania 65
788 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Switzerland 75
789 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 69
790 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 51
791 peripheral blood T-cell Acute lymphoblastic leukemia hematology 2017 standard therapy Australia 30
792 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy Estonia 67
793 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 70
794 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Belgium 34
795 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 68
796 peripheral blood myeloproliferative neoplasms hematology 2017 standard therapy Poland 7
797 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 52
798 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 59
799 peripheral blood myelofibrosis hematology 2017 standard therapy United Kingdom 55
800 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 62
801 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Poland 59
802 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Canada 67
803 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 67
804 peripheral blood β - Thalassemia Major hematology 2017 standard therapy India 4
805 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 48
806 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 53
807 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 55
808 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Czech Republic 62
809 peripheral blood acute myelogenous leukemia with myelodysplastic syndrome hematology 2017 standard therapy Germany 64
810 peripheral blood follicular CA hematology 2017 standard therapy South Africa 42
811 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Canada 63
812 peripheral blood chronic lymphocytic leukemia hematology 2017 standard therapy USA 65
813 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 35
814 peripheral blood other myleofibrosis hematology 2017 standard therapy USA 71
815 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 64
816 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 69
817 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 39
818 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 54
819 peripheral blood prolymphocytic leukemia hematology 2017 standard therapy Belgium 38
820 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 65
821 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 23
822 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Slovakia 54
823 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 35
824 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Finland 46
825 peripheral blood myelofibrosis hematology 2017 standard therapy Germany 29
826 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 63
827 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Czech Republic 12
828 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 29
829 peripheral blood no data hematology 2017 standard therapy Germany 65
830 peripheral blood chronic granulomatous disease hematology 2017 standard therapy Poland 4
831 peripheral blood no data hematology 2017 standard therapy Russia 36
832 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Turkey 58
833 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Turkey 54
834 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Netherlands 51
835 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Germany 60
836 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Germany 49
837 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 38
838 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 38
839 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Hungary 32
840 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy Poland 36
841 peripheral blood T-cell Acute lymphoblastic leukemia hematology 2017 standard therapy Poland 7
842 peripheral blood myelofibrosis hematology 2017 standard therapy USA 62
843 peripheral blood no data hematology 2017 standard therapy Kanada 32
844 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy France 63
845 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy France 63
846 peripheral blood primary Immunodeficiency hematology 2017 standard therapy Russia 4
847 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy France 39
848 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy USA 62
849 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 65
850 peripheral blood chronic myelomonocytic leukaemia hematology 2017 standard therapy USA 58
851 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Italy 67
852 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy USA 58
853 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Netherlands 51
854 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy USA 69
855 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Poland 19
856 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Switzerland 67
857 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 43
858 peripheral blood non-Hodgkin lymphoma hematology 2017 standard therapy USA 68
859 peripheral blood myelodysplastic syndrome hematology 2017 standard therapy Amsterdam 69
860 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Israel 11
861 peripheral blood acute lymphoblastic leukemia hematology 2017 standard therapy Canada 4
862 peripheral blood acute myelogenous leukemia hematology 2017 standard therapy Poland 42
863 peripheral blood myeloproliferative neoplasms hematology 2017 standard therapy Poland 7
864 peripheral blood no data hematology 2017 standard therapy Poland 58
865 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 58
866 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 56
867 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Austria 60
868 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 62
869 peripheral blood no data n/a 2016 standard therapy Czech Republic 45
870 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Slovakia 52
871 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 40
872 peripheral blood no data n/a 2016 standard therapy Netherlands 70
873 peripheral blood no data n/a 2016 standard therapy Poland 43
874 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 18
875 peripheral blood X-linked lymphoproliferative disease hematology 2016 standard therapy Russia 12
876 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Sweden 61
877 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
878 peripheral blood no data n/a 2016 standard therapy Netherlands 69
879 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Columbia 43
880 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 64
881 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Poland 31
882 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 54
883 peripheral blood T-cell leukemia/lymphoma hematology 2016 standard therapy Canada 31
884 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 54
885 peripheral blood primary myelofibrosis hematology 2016 standard therapy Germany 50
886 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 18
887 peripheral blood adrenoleukodystrophy metabolic 2016 standard therapy Poland 1
888 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 31
889 peripheral blood no data n/a 2016 standard therapy Poland 28
890 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Sweden 35
891 peripheral blood no data n/a 2016 standard therapy Czech Republic 1
892 peripheral blood Wiskott-Aldrich syndrome hematology 2016 standard therapy Poland 1
893 peripheral blood no data n/a 2016 standard therapy Belgium 30
894 peripheral blood no data n/a 2016 standard therapy Germany 71
895 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 46
896 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 29
897 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Czech Republic 56
898 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 32
899 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 49
900 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 50
901 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 64
902 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 42
903 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 13
904 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Slovakia 8
905 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Belgium 46
906 peripheral blood refractory anemia with excess blasts hematology 2016 standard therapy United Kingdom 62
907 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 40
908 peripheral blood myelodysplastic syndrome - RAEB hematology 2016 standard therapy Poland 56
909 peripheral blood no data n/a 2016 standard therapy Sweden 58
910 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Germany 32
911 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 32
912 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
913 peripheral blood T Cell Lymphoma/ NOS - Not otherwise specified hematology 2016 standard therapy Germany 55
914 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 43
915 peripheral blood no data n/a 2016 standard therapy Czech Republic 59
916 peripheral blood aplastic anaemia hematology 2016 standard therapy United Kingdom 23
917 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 73
918 peripheral blood myelofibrosis hematology 2016 standard therapy Israel 72
919 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Australia 61
920 peripheral blood primary myelofibrosis hematology 2016 standard therapy Germany 67
921 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Ireland 47
922 peripheral blood no data n/a 2016 standard therapy Germany 17
923 peripheral blood no data n/a 2016 standard therapy France 59
924 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
925 peripheral blood chronic lymphocytic leukemia hematology 2016 standard therapy Germany 62
926 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 47
927 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 67
928 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Lithuania 15
929 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy United Kingdom 18
930 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 37
931 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 24
932 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Canada 13
933 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Hungary 57
934 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Belgium 56
935 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 38
936 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 52
937 peripheral blood chronic myelomonocytic leukemia, minimal residual disease hematology 2016 standard therapy Poland 50
938 peripheral blood myeloma multiplex hematology 2016 standard therapy Germany 63
939 peripheral blood Fanconi anaemia hematology 2016 standard therapy Estonia 7
940 peripheral blood plasma cell disorder hematology 2016 standard therapy France 47
941 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 35
942 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 72
943 peripheral blood myeloma multiplex hematology 2016 standard therapy Poland 51
944 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Spain 58
945 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Estonia 62
946 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Hungary 46
947 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Hungary 20
948 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 51
949 peripheral blood primary Immunodeficiency hematology 2016 standard therapy Russia 5
950 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 62
951 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 69
952 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 51
953 peripheral blood no data n/a 2016 standard therapy Netherlands 58
954 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Spain 38
955 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Lithuania 23
956 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Germany 62
957 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Germany 32
958 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Germany 27
959 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 30
960 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 55
961 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Israel 63
962 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Turkey 37
963 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
964 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Turkey 38
965 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 65
966 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 46
967 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 18
968 peripheral blood Hodgkin’s lymphoma hematology 2016 standard therapy Netherlands 38
969 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 48
970 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 61
971 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 67
972 peripheral blood no data n/a 2016 standard therapy Poland 55
973 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 32
974 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Germany 19
975 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy United Kingdom 68
976 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 59
977 peripheral blood myelodysplastic syndrome - RCMD hematology 2016 standard therapy Czech Republic 32
978 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Belgium 65
979 peripheral blood myelofibrosis hematology 2016 standard therapy Netherlands 66
980 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Switzerland 2/3
981 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Israel 36
982 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 66
983 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Denmark 68
984 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Spain 15
985 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Italy 52
986 peripheral blood chronic myelomonocytic leukaemia hematology 2016 standard therapy Finland 53
987 peripheral blood no data n/a 2016 standard therapy Turkey 4
988 peripheral blood leukemia hematology 2016 standard therapy Lithuania 53
989 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Serbia 21
990 peripheral blood myeloproliferative syndrome hematology 2016 standard therapy Poland 52
991 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy France 63
992 peripheral blood no data n/a 2016 standard therapy Poland 44
993 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Czech Republic 60
994 peripheral blood T-cell acute lymphoblastic leukemia hematology 2016 standard therapy Austria 41
995 peripheral blood primary myelofibrosis hematology 2016 standard therapy Switzerland 67
996 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy United Kingdom 20
997 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Brazil 37
998 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 60
999 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 61
1000 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Turkey 51
1001 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 28
1002 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 65
1003 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 53
1004 peripheral blood Lymphoblastic Lymphoma hematology 2016 standard therapy Italy 33
1005 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Slovakia 30
1006 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Belgium 9
1007 peripheral blood myeloma multiplex hematology 2016 standard therapy Poland 38
1008 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 39
1009 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Austria 61
1010 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy New Zealand 59
1011 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Australia 62
1012 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 65
1013 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Portugal 41
1014 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy France 59
1015 peripheral blood SAA / Amyloidosis hematology 2016 standard therapy United Kingdom 45
1016 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Finland 46
1017 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 50
1018 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Italy 66
1019 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Russia 38
1020 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Poland 20
1021 peripheral blood myelofibrosis hematology 2016 standard therapy France 67
1022 peripheral blood B-cell Acute lymphoblastic leukemia hematology 2016 standard therapy Belgium 44
1023 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Poland 58
1024 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Germany 72
1025 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 68
1026 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 63
1027 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 56
1028 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 54
1029 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 24
1030 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Greece 9
1031 peripheral blood chronic myeloid leukemia hematology 2016 standard therapy Germany 40
1032 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 15
1033 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 37
1034 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Russia 44
1035 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 59
1036 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Russia 32
1037 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 62
1038 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 55
1039 peripheral blood composite lymphoma hematology 2016 standard therapy Germany 51
1040 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 30
1041 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Germany 33
1042 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Italy 58
1043 peripheral blood high-risk acute lymphoblastic leukemia hematology 2016 standard therapy Poland 5
1044 peripheral blood acute myelogenous leukemia M2/M4 hematology 2016 standard therapy Germany 59
1045 peripheral blood non-Hodgkin lymphoma hematology 2016 standard therapy Netherlands 39
1046 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy Italy 21
1047 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Spain 50
1048 peripheral blood plasma cell disorder hematology 2016 standard therapy France 54
1049 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy United Kingdom 47
1050 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Canada 47
1051 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 67
1052 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 62
1053 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Italy 63
1054 peripheral blood acute myelogenous leukemia hematology 2016 standard therapy Poland 19
1055 peripheral blood T-cell-prolymphocytic leukemia hematology 2016 standard therapy United Kingdom 61
1056 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy USA 69
1057 peripheral blood acute lymphoblastic leukemia hematology 2016 standard therapy France 35
1058 peripheral blood severe aplastic anaemia hematology 2016 standard therapy Russia 18
1059 peripheral blood myelodysplastic syndrome hematology 2016 standard therapy Germany 66
{{$index+1}} {{item.source}} {{item.indication}} {{item.area}} {{item.year}} {{item.therapy}} {{item.country}} {{item.age | number}}

Last update: 30.06.2017